Skip to content

Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy

Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00734838
Enrollment
213
Registered
2008-08-14
Start date
2006-01-31
Completion date
2022-10-03
Last updated
2023-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Breast Cancer, Breast Biopsy, Reduction mammoplasty

Brief summary

The objective of the proposed research is to develop new diagnostic modalities based on optical spectroscopy (auto fluorescence, absorption, and scattering) for the diagnosis of breast cancer and test its performance as an adjunct to core needle biopsy. For the surgery part of the study, all patients scheduled to have a mastectomy or lumpectomy for the treatment of breast cancer will be asked if they would be willing to participate in this study. For the core needle biopsy part of the study, patients with a higher pre-probability of cancer (based on mammography) will be recruited to increase the number of patients with malignant lesions and enrolled in this investigation.

Interventions

Using core biopsy and reduction mammoplasty tissue

Sponsors

William Marsh Rice University
CollaboratorOTHER
Duke University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients having a needle biopsy of a breast mass

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Optical signaturesDay of procedure (less than 10 minutes)The primary outcome of this study is the identification of the optical signatures of normal and cancerous tissue of the breast

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026